BPA Call 36C25225A0002-36C25225N0135

Award Date 10/1/24
Potential Completion Date 9/30/25
Potential Value $54K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Emigration Canyon, UT 84108, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Biomerieux Inc., through its Biomerieux, Inc. Division, is for the provision of multiplex PCR reagents and consumables. The contract has a ceiling value of $87,381.60 and a period of performance ending on September 30, 2025. It is a Blanket Purchase Agreement (BPA) call under the Federal Supply Schedule (FSS) contract for In Vitro Diagnostics, Reagents, and Test Kits. The funding agency is the Veterans Integrated Service Network 12, a civilian agency within the...
This is a Federal contract award to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of multiplex PCR reagents and consumables. The contract, valued at $333,130.72, was awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs. The contract is a Blanket Purchase Agreement (BPA) Call under the Federal Supply Schedule for In Vitro Diagnostics, Reagents, and Test Kits. The contract has a period of performance through...
This is a firm-fixed-price Blanket Purchase Agreement (BPA) call awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs to Biomerieux Inc. through its Biomerieux, Inc. division. The contract is for the provision of multiplex PCR reagents and consumables, valued at $362,338.16 and with a period of performance through September 30, 2025. Biomerieux Inc. is a global leader in in vitro diagnostics, specializing in microbiological testing...
This federal contract award is for the provision of MULTIPLEX PCR REAGENTS AND CONSUMABLES to the Department of Veterans Affairs, Integrated Service Network 12. The award was made to Biomerieux Inc., a global leader in in vitro diagnostics, through its Biomerieux, Inc. division. The contract is a Blanket Purchase Agreement (BPA) call under the Invitro Diagnostics, Reagents, Test (FSS-65-VII) Federal Supply Schedule, with a ceiling value of $1,182,946.32 and a period of performance through...
This is a federal contract award to Biomerieux Inc., doing business as Vitek Systems, Inc., by the U.S. Department of Veterans Affairs (VA) for the supply of multiplex PCR reagents and consumables. The contract is a Blanket Purchase Agreement (BPA) call with a ceiling value of $266,778.40 and a period of performance through September 30, 2026. The contract is not set aside for any specific business category. Biomerieux Inc. is a global leader in in vitro diagnostics and microbiological testing...
This is a Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) to Biomerieux Inc., doing business as Vitek Systems Inc., for the supply of multiplex PCR reagents and consumables. The $45,733.44 firm-fixed-price contract has a completion date of September 30, 2026. Biomerieux is a global leader in in vitro diagnostics and microbiological testing solutions, specializing in the manufacture of advanced diagnostic equipment, reagents, test kits, and clinical...
This is a federal contract award for multiplex PCR reagents and consumables, awarded by the Veterans Integrated Service Network 12 (VISN 12) to Biomerieux Inc., doing business as Vitek Systems, Inc. The contract has a ceiling value of $1,219,299.04 and a performance period through September 30, 2026. It is a Blanket Purchase Agreement (BPA) call order under the General Services Administration (GSA) Federal Supply Schedule 65-VII for In Vitro Diagnostics, Reagents, and Test Kits. The contract...
This federal contract award is for a Blanket Purchase Agreement (BPA) call with Biomerieux Inc., a global leader in in vitro diagnostics and microbiological testing solutions. The $117,784.40 firm-fixed-price contract is to provide the Department of Veterans Affairs' Veterans Integrated Service Network 2 (VISN 2) with diagnostic equipment, reagents, test kits, and related services. The contract has an option year from October 1, 2025 to September 30, 2026 and does not have a set-aside...
This federal contract award was made to Biomerieux Inc., a global leader in in vitro diagnostics, through its Biomerieux, Inc. Division. The contract, valued at $120,932.84, is a Blanket Purchase Agreement (BPA) call with a firm-fixed-price pricing type. The contract has a period of performance from October 1, 2024, to September 30, 2025, and does not have a set-aside designation. Biomerieux Inc. was awarded this contract by the Veterans Integrated Service Network 2, a civilian agency within the...
This is a federal contract award to Biomerieux Inc., a global leader in in vitro diagnostics, for the supply of BioFire consumables. The $1,201,831.64 firm-fixed-price contract was awarded by the Veterans Integrated Service Network 17 (VISN 17), a division of the Department of Veterans Affairs. The contract is a Blanket Purchase Agreement (BPA) call under Biomerieux's existing Federal Supply Schedule contract for In Vitro Diagnostics, Reagents, and Test Kits. This contract does not involve any...

This federal contract award to Biomerieux Inc., through its Biomerieux, Inc. Division, is for the provision of multiplex PCR reagents and consumables. The $53,518.72 firm-fixed-price contract was awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs. The contract has a period of performance through September 30, 2025 and is a Blanket Purchase Agreement (BPA) call order. Biomerieux Inc. is a global leader in in vitro diagnostics, specializing in microbiological testing solutions for medical, food safety, and industrial applications. The company provides a wide range of clinical diagnostic equipment, reagents, and supplies to various federal agencies. This contract does not have a set-aside designation, as Biomerieux is often the sole source provider for its proprietary technologies.

Generated 2/8/25, 9:11 AM